Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14312226 | 0.97 | LMNA (0.62) | — | |
| SCHEMBL34825 | 0.97 | — | — | |
| SCHEMBL11638094 | 0.94 | — | — | |
| SCHEMBL28706371 | 0.94 | — | — | |
| SCHEMBL27448910 | 0.94 | — | — | |
| SCHEMBL10513220 | 0.94 | — | — | |
| Ammonia Solution, Strong SCHEMBL8585484 | 0.94 | — | — | |
| SCHEMBL27915230 | 0.94 | — | — | |
| Methane SCHEMBL21523876 | 0.94 | — | — | |
| Hydrochloric Acid SCHEMBL1478913 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100022415-A1 | ACTIVE CARRIER, ITS PRODUCTION AND ITS USE | AVICOR KET. (HU) | 2010-01-28 | — | — | US | claimed |
| EP-2080026-A1 | ACTIVE CARRIER, ITS PRODUCTION AND ITS USE | Avicor Kft. (HU) | 2009-07-22 | — | — | EP | claimed |
| WO-2008023208-A1 | ACTIVE CARRIER, ITS PRODUCTION AND ITS USE | AVICOR KFT. (HU) | 2008-02-28 | — | — | WO | claimed |
| US-20060019565-A1 | Method for delivering biologically active substnces | CIBA SPECIALTY CHEMICALS CORP. | 2006-01-26 | — | — | US | claimed |
| EP-1532310-A1 | METHOD FOR DELIVERING BIOLOGICALLY ACTIVE SUBSTANCES | Ciba SC Holding AG (CH) | 2005-05-25 | — | — | EP | claimed |
| WO-2004020729-A1 | METHOD FOR DELIVERING BIOLOGICALLY ACTIVE SUBSTANCES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-03-11 | — | — | WO | claimed |
| EP-0864564-B1 | Method for the preparation of alpha-bromolactam derivatives | BASILEA PHARMACEUTICA AG (CH) | 2002-06-12 | — | — | EP | claimed |
| US-6114541-A | Method for the preparation of α-Bromo-Lactam derivatives | HOFFMANN-LA ROCHE INC. (US) | 2000-09-05 | — | — | US | claimed |
| EP-0864564-A1 | Method for the preparation of alpha-bromolactam derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1998-09-16 | — | — | EP | claimed |
| JP-60197636-A | — | — | None | — | — | JP | disclosed |
| US-20250382265-A1 | MODIFIED AMINO ACID DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISEASES AND SELECTED PSYCHIATRIC DISORDERS | UNIV JAGIELLONSKI (PL) | 2025-12-18 | — | — | US | disclosed |
| EP-4623910-A2 | MODIFIED AMINO ACID DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISEASES AND SELECTED PSYCHIATRIC DISORDERS | UNIWERSYTET JAGIELLONSKI (PL) | 2025-10-01 | — | — | EP | disclosed |
| US-12421189-B2 | Modified amino acid derivatives for the treatment of neurological diseases and selected psychiatric disorders | UNIWERSYTET JAGIELLONSKI (PL) | 2025-09-23 | — | — | US | disclosed |
| EP-3956310-B1 | MODIFIED AMINO ACID DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISEASES AND SELECTED PSYCHIATRIC DISORDERS | UNIV JAGIELLONSKI (PL) | 2025-08-06 | — | — | EP | disclosed |
| US-3962283-A | TERPENE FLAVORANT INTERMEDIATES | GIVAUDAN CORPORATION (US) | 1976-06-08 | — | — | US | disclosed |
| US-3960890-A | CONTROL OF ECTOPARASITES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-06-01 | — | — | US | disclosed |
| US-3950430-A | Process for preparation of terpene flavorants and novel intermediates therefor | GIVAUDAN CORPORATION (US) | 1976-04-13 | — | — | US | disclosed |
| US-3941789-A | CNS DEPRESSANT, ADRENOLYTIC, ANTIPHLOGISTIC, ANALGESIC, ANTIHISTAMINE, ANTICHOLESTEROL | BOEHRINGER INGELHEIM GMBH (DT) | 1976-03-02 | — | — | US | disclosed |
| US-3939206-A | Process for preparation of terpene flavorants and novel intermediates therefor | GIVAUDAN CORPORATION (US) | 1976-02-17 | — | — | US | disclosed |
| US-3935275-A | Process for preparation of terpene flavorants and novel intermediates therefor | GIVAUDAN CORPORATION (US) | 1976-01-27 | — | — | US | disclosed |